This publication aims to improve treatment and care for adults with chronic obstructive pulmonary disease (COPD). It provides commissioners with strategies and recommendations for frontline care, ...

The primary finding from the clinical trials for the COPD biologics is reduced annual exacerbations by 30% (BOREAS trial) and 34% (NOTUS trial). In the BOREAS trial, in addition to reduced ...

Researchers at the UNC School of Medicine have developed a tool that can identify airway mucus abnormalities in patients with ...

Stopping long-acting inhalers for chronic obstructive pulmonary disease (COPD) can lead to a sharp rise in flare-ups for ...

When appropriate, surgery remains the most effective treatment option for non-small cell lung cancer (NSCLC), including for patients with COPD, said Friedberg, professor in the Department of Thoracic ...

GSK’s Nucala receives European Commission approval to treat chronic obstructive pulmonary disease: London, UK Saturday, February 7, 2026, 09:00 Hrs [IST] GSK plc announced the E ...

Three Dog Night founding member Chuck Negron died Monday at 83 from complications of heart failure and chronic obstructive pulmonary disease at his home.

Some healthy habits can help reduce your chances of getting lung infections while living with COPD. Learn more here.

Oral health is not just about teeth; it is deeply connected to overall health. Proper oral care help reduce risks of chronic ...

Do vitamin K antagonists affect COPD outcomes? New cohort data explore exacerbation and mortality risk compared with DOACs.

As the world marks Rare Disease Month, health experts are calling attention to conditions that often go unnoticed—despite their life-threatening impact. One such condition is Pulmonary Arterial ...

GSK (GSK) on Friday announced that the European Commission has approved its Nucala asthma therapy for patients with chronic ...